South Korea Insulin Drugs and Delivery Devices Market Insight
Published: 25 July 2026 | Report Format: Electronic (PDF) | Author: Sanket and Pranali
The market for insulin medications and delivery systems in South Korea is expected to grow at compound annual growth rate (CAGR) of 7.23% due to the growing prevalence of diabetes.
South Korea Insulin Drugs and Delivery Devices Market Insights Forecasts to 2035
- The South Korea Insulin Drugs and Delivery Devices Market Size Was Estimated USD 985.4 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 7.23% from 2025 to 2035
- The South Korea Insulin Drugs and Delivery Devices Market Size is Expected to rise around USD 1980.6 Million by 2035
Notable Insights for the South Korea Car Rental Market
- According to drug segmentation, the largest proportion is held by basal and bolus insulins, while the fastest-growing sector is biosimilar insulins because of their affordability.
- According to device segmentation, insulin pens are extensively used, but because of technical advancements, insulin pumps are expanding at a rate of more than 3.9% CAGR.
- In 2024, South Korea's NHI diabetes consumable claims were about KRW 112.2 billion, demonstrating the government's support for diabetes care infrastructure.
- The government gave Celltrion KRW 3 billion to create an insulin biosimilar with the goal of commercializing it by 2025 to lessen reliance on imports.
Download the eBook (ToC)
Research Methodologies Used to Analyze the South Korea Insulin Drugs and Delivery Devices Market
The South Korea insulin drugs and delivery devices market is looked at closely. This is done by talking to people who make insulin and devices that deliver it. We want to know what is popular and what is new. We also read a lot of reports and papers to get information. These reports are from companies and the government. This information is important, for people who want to invest in the South Korea insulin drugs and delivery devices market. We are looking at what will happen until 2035. The South Korea insulin drugs and delivery devices market is very important because many people need insulin to stay healthy.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors do a lot of research to understand what is happening in the market. They look closely at what's going on in each industry. They also compare companies to see how they are doing. They try to figure out what will happen in the future with trends and they use data to help businesses make decisions.
Competitive Analysis:
The report gives us a look at the main companies, in the South Korea insulin drugs and delivery devices market. It compares these companies based on the products they offer, what they do, where they are and the strategies they use. We also get to see how much of the market each company has. The report looks at the strengths and weaknesses of each company. We see when companies work together merge with others or make partnerships. All of this helps us understand how competitive the South Korea insulin drugs and delivery devices market really is.
Top Companies in South Korea Insulin Drugs and Delivery Devices Market
- Celltrion
- Hanmi Pharmaceutical
- LG Chem
- Dong-A ST
- Huons
- Daewoong Pharmaceutical
- EOFlow Co., Ltd.
- CareMedi
- Poonglim Pharmatech
- Isu Abxis
Recent Developments:
- In May 2025, expanded its range of cutting-edge chronic disease management treatments while working with domestic medical institutes to promote diabetes treatment research.
- In January 2025, they came out with injectable medication delivery systems. These systems are helpful for patients because they make it easier for people with diabetes to give themselves insulin shots. The systems are very useful.
Market Segmentation:
South Korea Insulin Drugs and Delivery Devices Market, By Drug Type
- Basal or Long-Acting Insulins
- Bolus or Fast-Acting Insulins
- Traditional Human Insulins
- Biosimilar Insulins
South Korea Insulin Drugs and Delivery Devices Market, By Device Type
- Insulin Pumps
- Insulin Pens
- Insulin Syringes
- Insulin Jet Injectors
South Korea Insulin Drugs and Delivery Devices Market, By End-User
- Type 1 Diabetes Patients
- Type 2 Diabetes Patients
Expert Views:
There are favorable growth prospects for the South Korea insulin drugs and delivery devices market in the years to come due to an increasing number of diabetes patients, increased uptake of novel insulin delivery systems, and supportive reimbursement policies in healthcare. Innovative biosimilar insulins, insulin delivery devices, and technology-enabled diabetes management platforms will boost competition in the market, while investments and production in the country will help to foster industry growth till 2035.
Author: Sanket and Pranali By Decisions Advisors and Consulting